Cancer Alliance Data Pack

Transcription

1 Surrey and Sussex Cancer Alliance Data Pack By February 18 Version 1.1 Produced by the Cancer Alliance Data, Evidence and Analysis Service (CADEAS) For any enquiries contact:

2 Contents 1 Summary of key findings 2 About the data pack 3 How to interpret the data 4 Further data releases 5 Alliance key indicators grid 6 Alliance key indicators grid, with values 7 Alliance indicators by Outcome indicators One-year age-standardised net cancer survival Under-75 age-standardised cancer mortality rate Cancer prevalence Patient experience: rating of overall care Pathway indicators Bowel screening uptake and coverage Breast screening uptake and coverage Cervical screening coverage Cancers diagnosed through an emergency presentation Routes to diagnosis: breast, colorectal, lung and prostate cancer Cancer waiting times: two-week wait and 62-day standard Age-standardised cancer incidence rate Cancers diagnosed at stage 1+2 Cancers staged Median waiting times: prostate, colorectal and lung cancer 8 Annex of data sources This data pack uses information provided by patients and collected by the NHS as part of their care and support Version Number Detail Date 1. Initial release 12/2/ Text in the pack has been updated to reflect change from internal to public use /11/18 CADEAS Alliance Data Pack by 2

3 1. Summary of key findings The Surrey and Sussex Cancer Alliance The latest available data on some key cancer indicators suggest the standard of cancer care in the Cancer Alliance was mixed. Guildford and Waverly and Horsham and Mid Sussex s had the most indicators that were better than the England average. In contrast, Brighton and Hove, and North West Surrey s performed worse than the England averages on a number of indicators. Screening: Screening uptake and coverage were generally similar to, or better than, the England average across all s, with the exception of Brighton and Hove, and North West Surrey s who performed below England levels across all screening programmes. Emergency presentations: Emergency presentations were in line with, or better than, the England average in all s except and and Farnham s. Cancer waiting times: Two-week waiting times were exceeded in all s, except in Horsham and Mid Sussex, where it was lower than expected. The 62-day standard was met in four s: Guildford and Waverley, and Farnham, Surrey Downs and s. Early diagnosis: The proportions of cancers diagnosed at an early stage was generally similar to England levels in all but two s ( and and Farnham s). In Horsham and Mid Sussex the proportion of early stage diagnoses was higher than the England average. Survival: One-year survival was mixed in the Alliance with the majority of s reporting better survival outcomes than England levels, with poorer survival in four s (Brighton and Hover,, and Seaford, and Hastings and Rother s). Mortality: Under-75 mortality was similar to, or better than, the England average in all s. Patient experience: Patient reported experience of care was in line with the England level., except in, where it was better. CADEAS Alliance Data Pack by 3

4 2. About the data pack Cancer Alliances were formed as a result of recommendations in the 15 Independent Cancer Taskforce's Achieving World-Class Cancer Outcomes report. The 19 Alliances lead on the local delivery of the Cancer Strategy Implementation Plan, using a whole pathway and cross-organisational approach. CADEAS is a partnership between NHS England and Public Health England. The service supports Alliances with their data, evidence and analysis needs, to help drive evidencebased local decisions in the delivery of the Cancer Strategy Implementation Plan. This data pack aims to provide all Cancer Alliances in England with a snapshot of cancer in their local populations, with a breakdown by Clinical Commissioning Group (). 3. How to interpret the data This data pack highlights variation in cancer services across s in the Alliance. By using a colour coding system Alliances can identify where variation exists and prioritise areas for action. Data here should be considered alongside other sources of information for contextual and richer interpretation. The colour system: broadly, yellow indicates data are similar to the England level. Dark blue shows data are better than England and light blue indicates data are worse than England. Some metrics have been benchmarked to operational standards or expected values; these are denoted in the legends and in the Annex. All statistical tests for England benchmarking have been conducted using a 95% confidence level. At the time this report was made, there were three sites of the National Cancer Vanguard and 16 Alliances and the metric geography labels reflect this. Information on data sources can be found in the Annex. 4. Data releases CADEAS have released the following products,containing data metrics for the Cancer Alliances: A one-off level data pack for each of the 19 Cancer Alliances, to enable comparisons across s within an Alliance. Indicator summary grids comprising key indicators for each Alliance, available at, STP and Alliance levels. These are similar to the grids found in sections 5 and 6 of this data pack and are published by CADEAS on a monthly basis. CADEAS Alliance Data Pack by 4

5 One-year cancer survival Under 75 cancer mortality age-standardised rate Patient experience Bowel screening coverage (-69) Bowel screening uptake (-69) Bowel screening coverage (-74) Bowel screening uptake (-74) Breast screening coverage Breast screening uptake Cervical screening coverage Emergency presentations Cancer Waiting Times: Two-Week Wait Cancer Waiting Times: 62-day Standard Incidence age-standardised rate Early stage diagnosis Cancers staged 5. Cancer Alliance key indicators grid, by Statistically worse than England Excludes routes to diagnosis, prevalence and pathway median waiting times. This is due to the volume of data in these three areas. Please see data in rest of data pack CADEAS Alliance Data Pack by 5

6 One-year cancer survival Under 75 cancer mortality age-standardised rate Patient experience Bowel screening coverage (-69) Bowel screening uptake (-69) Bowel screening coverage (-74) Bowel screening uptake (-74) Breast screening coverage Breast screening uptake Cervical screening coverage Emergency presentations Cancer Waiting Times: Two-Week Wait Cancer Waiting Times: 62-day Standard Incidence age-standardised rate Early stage diagnosis Cancers staged 6. Cancer Alliance key indicators grid, by Statistically worse than England Excludes routes to diagnosis, prevalence and pathway median waiting times. This is due to the volume of data in these three areas. Please see data in rest of data pack CADEAS Alliance Data Pack by 6

7 Rate per, Survival (%) 7. Alliance indicators by Cancer survival One-year index of cancer survival, all cancers, adults diagnosed in 15 and followed up to Statistically worse than England Taskforce Ambition (75% by ) England (72.3%) Cancer mortality Age-standardised mortality rate for all cancers, patients under 75, Statistically worse than England England (136.6 per, population) CADEAS Alliance Data Pack by 7

8 < 1 yr 1 yrs - < 2 yrs Cases Crude Rates per, (cases / total population in 15) 2 yrs - < 5 yrs 5 yrs - < yrs yrs - < 15 yrs ,885 2,93 1, ,593 2,73 4,875 5,166 3,296 2, , ,384 1,548 1, ,694 1,99 1, , ,669 1,885 1, ,549 1, , ,614 1,741 1, , ,898 2, 1, ,649 1,877 1, ,28 1,123 2,6 3,73 1,678 1, ,218 1,93 2,473 3,13 2,41 1, , yrs - < 21 yrs < 1 yr 1 yrs - < 2 yrs 2 yrs - < 5 yrs 5 yrs - < yrs yrs - < 15 yrs 15 yrs - < 21 yrs Cancer prevalence Patients diagnosed with cancer between (inclusive) alive on the 31st December 15 (21-year prevalence) Number of cases and crude rates are in year bands representing time since diagnosis CADEAS Alliance Data Pack by 8

9 Average score from very poor () to very good () Cancer patient experience Patient overall rating of cancer care, case-mix adjusted, Statistically worse than England England (Score: 8.7) CADEAS Alliance Data Pack by 9

10 Bowel cancer screening, ages -69 % Persons, aged -69, screened for bowel cancer in last months (2.5 year coverage), 16/ Statistically worse than England England (57.5%) Persons, aged -69, screened for bowel cancer within 6 months of invitation (uptake), 16/17 % Statistically worse than England England (57.1%) CADEAS Alliance Data Pack by

11 Bowel cancer screening, ages -74 % Persons, aged -74, screened for bowel cancer in last months (2.5 year coverage), 16/ Statistically worse than England England (59.2%) Persons, aged -74, screened for bowel cancer within 6 months of invitation (uptake), 16/ % Statistically worse than England England (59%) CADEAS Alliance Data Pack by 11

12 Breast cancer screening % 9 8 Females, aged -, screened for breast cancer in last 36 months (3 year coverage), 16/ Statistically worse than England England (72.5%) % Females, aged -, screened for breast cancer within 6 months of invitation (uptake), 16/ Statistically worse than England England (72.2%) CADEAS Alliance Data Pack by 12

13 Emergency Presentation (%) Cervical cancer screening Females, aged 25-64, attending cervical screening within target period (3.5 or 5.5 year coverage), 16/17 % Statistically worse than England England (72.1%) Emergency presentations Cancers diagnosed through emergency presentation, year to June Statistically worse than England England (19.4%) CADEAS Alliance Data Pack by 13

14 Routes to diagnosis Routes to diagnosis for breast cancer in England, 6-15 Screen Detected Managed Emergency Presentation Other Number of Cases 24% 63% 5% 8% 1,875 27% 61% 4% 9% 5,145 28% 61% 4% 8% % 55% 3% 11% 1,485 28% % 5% 7% 1,825 % 49% 5% 16% 1,777 27% 63% 5% 5% 1,83 29% 57% 4% 9% 1,672 26% % 4% 11% 1,939 24% 54% 4% 19% 1,565 28% 56% 4% 13% 2,791 % 54% 3% 12% 2,594 27% 55% 3% 15% 791 Routes to diagnosis for colorectal cancer in England, 6-15 Screen Detected Managed Emergency Presentation Other Number of Cases 5% 44% 28% 23% 1,431 7% 57% 22% 14% 4,43 6% 54% 22% 18% 562 7% 51% 21% 21% 1,134 6% 61% 22% 12% 1,646 8% 54% 21% 17% 1,166 6% 55% 29% 11% 1,544 6% % 25% 19% 1,181 7% 48% 22% 22% 1,383 8% 52% % % 1,225 7% 49% 26% 18% 2,256 6% 53% 22% 19% 1,867 9% 48% 23% % 571 Statistically worse than England CADEAS Alliance Data Pack by 14

15 Routes to diagnosis Routes to diagnosis for lung cancer in England, 6-15 Managed Emergency Presentation Other Number of Cases 49% 36% 15% 1,515 55% 32% 13% 3,548 41% 45% 14% % 43% 16% % 34% 13% 1,368 % 35% 16% % 39% 12% 1,464 % 34% 16% % 38% 17% 1,1 29% 33% 39% 1,57 48% 34% 18% 1,895 47% 37% 16% 1,545 32% 33% 35% 482 Routes to diagnosis for prostate cancer in England, 6-15 Managed Emergency Presentation Other Number of Cases 77% % 13% 1,572 81% 6% 13% 4,695 79% 8% 13% % 9% 18% 1,215 77% % 13% 1,2 76% 7% 18% 1,7 8% % % 1,557 77% 9% 13% 1,1 76% 8% 16% 1,7 69% 6% 24% 1,272 % 12% 18% 2,275 69% 9% 22% 2,251 % 7% 24% 679 Statistically worse than England CADEAS Alliance Data Pack by 15

16 Total Seen Q3: Oct-Dec 16/17 Q4: Jan-Mar 16/17 Q1: Apr-Jun 17/18 Q2: Jul-Sep 17/18 Seen After 14 Days Seen Within 14 Days Total Seen Seen After 14 Days Seen Within 14 Days Total Seen Seen After 14 Days Seen Within 14 Days Total Seen Seen After 14 Days Seen Within 14 Days 2, % 2, % 2, % 2, % 4, % 4, % 4, % 4, % 1, % 1, % 1, % 1, % 1, % 1, % 1, % 1, % 2, % 2, 25 99% 2, % 2, % 1,321 3 % 1, % 1, % 1, % 1, % 1, % 1,938 95% 1, % 1, % 1, % 1, % 1, % 2, % 2, % 2, % 2, % 1, % 1, % 1, % 1, % 2, % 2, % 2, % 2, % 2, % 2, 58 97% 2,6 5 95% 2, % % % % % Cancer waiting times: two-week wait Two-week wait for all cancers, year to Sep 17 CADEAS Alliance Data Pack by 16

17 Total Seen Q3: Oct-Dec 16/17 Q4: Jan-Mar 16/17 Q1: Apr-Jun 17/18 Q2: Jul-Sep 17/18 Seen After 62 Days Treated Within 62 Days Total Seen Seen After 62 Days Treated Within 62 Days Total Seen Seen After 62 Days Treated Within 62 Days Total Seen Seen After 62 Days Treated Within 62 Days % % % % % % % % % % % % % % % % % % % % % % % % % 164 % % % % % % % % 6 81% % % % % % % % % % % 7 9% % % % % 6 88% % % Cancer waiting times: 62-day standard 62-day standard for all cancers, year to Sep 17 CADEAS Alliance Data Pack by 17

18 Patients seen within 62 days (%) Patients seen within 14 days (%) Cancer waiting times: two-week wait 9 8 Two-Week Wait for all cancers, year to Sep Same as operational standard Below operational standard Above operational standard England (94.5%) Operational Standards (93%) Cancer waiting times: 62-day standard day wait for first treatment for all cancers, year to Sep Same as operational standard Below operational standard atandard Above operational standard England (81.6%) Operational Standards (85%) CADEAS Alliance Data Pack by 18

19 Early Diagnosis (%) Rate per, Cancer incidence 8 Age-standardised incidence rate for all cancers, Statistically worse than England England (5 per, population) Early diagnosis Cancer diagnosed at stage 1 or 2 as a proportion of all staged and unstaged cancers ( cancers only*), year to December Statistically worse than England England (52.6%) * Invasive malignancies of breast, prostate, colorectal, lung, bladder, kidney, ovary and uterus, non-hodgkin lymphomas, and melanomas of skin CADEAS Alliance Data Pack by 19

20 Median number of days Cancers Staged (%) Cancers staged Cancers staged ( cancers*), Statistically worse than England England (9.83%) * Invasive malignancies of breast, prostate, colorectal, lung, bladder, kidney, ovary and uterus, non-hodgkin lymphomas, and melanomas of skin Median waiting times: Colorectal cancer pathway Median waiting times (days): Colorectal cancer pathway, Referral to First Seen First Seen to Diagnosis Diagnosis to MDT MDT to Treatment CADEAS Alliance Data Pack by

21 Median number of days Median number of days Median waiting times: Lung cancer pathway Median waiting times (days): Lung cancer pathway, Referral to First Seen First Seen to Diagnosis Diagnosis to MDT MDT to Treatment Median waiting times: Prostate cancer pathway Median waiting times (days): Prostate cancer pathway, Referral to First Seen First Seen to Diagnosis Diagnosis to MDT MDT to Treatment CADEAS Alliance Data Pack by 21

22 8. Annex: Data sources Indicator Year Source Cancer outcomes One-year cancer survival Under-75 mortality agestandardised rate Prevalence Patients overall rating of cancer care (case-mix adjusted) Patients followed up in year prevalence patients who are alive on the 31st December alcare/conditionsanddiseases/bulletins/indexofcancersurvivalforclinicalc ommissioninggroupsinengland/adultsdiagnosedto15andfollowed upto16/relateddata Benchmark: England Extracted from CancerStats Benchmark: England National Cancer Patient Experience Survey Benchmark: Expected values Cancer pathway Screening uptake and coverage Two-week waiting time standard 62-day waiting time standard Cancers diagnosed through emergency presentation Routes to diagnosis (all malignant neoplasms) 16/17 Quarterly Q3 16/17 to Q2 17/18; Year to Q2 17/18 Quarterly Q3 16/17 to Q2 17/18; Year to Q2 17/18 Year to Q Incidence rate 15 Cancers diagnosed at stage 1 & 2 (note this is based on the IAF definition and includes data for tumours only) Cancers staged 15 Pathways (median times) 15 Year to Q3 16 Confidence interval based on Wilson method Benchmark: England Benchmark: Operational Standard Benchmark: Operational Standard Confidence interval based on Wilson method Benchmark: England Benchmark: England Extracted from CancerStats Benchmark: England Confidence interval based on Wilson method Benchmark: England Confidence interval based on Wilson method. Extracted from CAS Benchmark: England NCRAS analysis using CAS data, based on TSCT-NCRAS work, using the CWT field REFERRAL_DATE: CADEAS Alliance Data Pack by 22